Post-translational regulation of arf: Perspective in cancer

Jinho Seo, Daehyeon Seong, Seung Ri Lee, Doo Byoung Oh, Jaewhan Song

Research output: Contribution to journalReview articlepeer-review

Abstract

Tumorigenesis can be induced by various stresses that cause aberrant DNA mutations and unhindered cell proliferation. Under such conditions, normal cells autonomously induce defense mechanisms, thereby stimulating tumor suppressor activation. ARF, encoded by the CDKN2a locus, is one of the most frequently mutated or deleted tumor suppressors in human cancer. The safeguard roles of ARF in tumorigenesis are mainly mediated via the MDM2-p53 axis, which plays a prominent role in tumor suppression. Under normal conditions, low p53 expression is stringently regulated by its target gene, MDM2 E3 ligase, which induces p53 degradation in a ubiquitin-proteasome-dependent manner. Oncogenic signals induced by MYC, RAS, and E2Fs trap MDM2 in the inhibited state by inducing ARF expression as a safeguard measure, thereby activating the tumor-suppressive function of p53. In addition to the MDM2-p53 axis, ARF can also interact with diverse proteins and regulate various cellular functions, such as cellular senescence, apoptosis, and anoikis, in a p53-independent manner. As the evidence indicating ARF as a key tumor suppressor has been accumulated, there is growing evidence that ARF is sophisticatedly fine-tuned by the diverse factors through transcriptional and post-translational regulatory mechanisms. In this review, we mainly focused on how cancer cells employ transcriptional and post-translational regulatory mechanisms to manipulate ARF activities to circumvent the tumor-suppressive function of ARF. We further discussed the clinical implications of ARF in human cancer.

Original languageEnglish
Article number1143
Pages (from-to)1-21
Number of pages21
JournalBiomolecules
Volume10
Issue number8
DOIs
Publication statusPublished - 2020 Aug

Bibliographical note

Funding Information:
Funding: This research was funded by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning, grant numbers 2015R1A3A2066581 and 2020R1C1C1006833; Brain Korea 21 (BK21) PLUS program; Next-Generation BioGreen 21 Program of the Rural Development Administration, grant number PJ013320; and Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program.

Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology

Fingerprint Dive into the research topics of 'Post-translational regulation of arf: Perspective in cancer'. Together they form a unique fingerprint.

Cite this